Restarting clinical research at NUH
Since the COVID-19 pandemic was first declared we have taken a number of steps to protect our patients involved in clinical research. These steps include the safe continuation of trials providing essential clinical treatments, as well as directing our resources to support local, national and international COVID-19 research.
Our staff and resources continue to be redeployed into the national priority research programme to rapidly evaluate new treatments, tests and vaccines for COVID-19. Thousands of patients and staff have taken part in vital COVID-19 research at NUH, for which we are incredibly grateful.
As cases increase in the Nottingham and Nottinghamshire areas, we are operating flexibly to esnure that we meet the rising numbers of patients and staff who are eligible to take part in COVID-19 research.
Our planned programme of clinical research is being prioritised to meet the urgent health needs of our patients and communities. As well as COVID-19, this includes trials which offer life-changing or life-saving treatments.
We are putting the safety of our patients and our staff as the number one priority in our research. Information about taking part in research trials at NUH for patients can be found on our Patient and Public Involvement pages.
Restart process for researchers
In order to prioritise the trials and studies, our Research & Innovation department has put in place a Restart Research process so that Principal Investigators, research teams and frontline research delivery staff have clarity.
We have produced a number of documents to explain this process and the actions that Principal Investigators and research teams should take when studies are able to restart. These are available to read and download in the drop down menu - Documents - below.
Our plans are being developed in line with the National Institute for Health Research restart framework https://www.nihr.ac.uk/documents/restart-framework/24886 and guidance from the Government including how to travel safely and working in indoor labs and research facilities and similar environments.
For more information
If you are a Principal Investigator or a researcher involved in clinical research at Nottingham University Hospitals, the NIHR Nottingham Biomedical Research Centre or the NIHR Nottingham Clinical Research Facility please email us if you have any questions about carrying out research during COVID-19.
Explaining the restart process
The process for Research Restart is explained in the document below. Please read this before completing the Study Restart document.
Please complete and return
Please complete the Study Restart document below, to request the resumption or the initiation of your research.
- PDF version Study Restart Document A4-v2.pdf [pdf] 73KB or
- Word version Study Restart Document WordV2.0.docx[docx] 82KB
To help you complete your request
This guidance document aims to provide additional information to help you complete the Study Research document.
Frequently Asked Questions
The latest version of FAQs on Research Restart are available below:
Patient screening questionnaire
Questionnaire to be completed for all patients attending NUH for research appointments. Please download a copy.
This is the latest version of the staff resource plan. Clinical Research Workforce Delivery Plan A4-v2.pdf [pdf] 2MB
Working from the R&I offices from 1 September onwards
Clinical Research Patient Pathway
Flow diagram for managing patient appointments as part of Restart.
Using video consultations in the NHS
Guidance for NHS staff on the best use of video consultations.
Information for patients and carers
Please find below information about restarting our research and different ways of involving patients and the public in our research. Please click on the link to view or download.